F2 Vision SCS - 10%+ Owner at Cullinan Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
10%+ Owner
Stock Symbol
CGEM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by F2 Vision SCS since 8/21/2023

Holdings reported by F2 Vision SCS for Cullinan Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.26M $15.6M $12.46 Aug 4, 2022 Direct
Common Stock 1.14M $14.2M $12.46 Aug 2, 2022 By Globeways Holdings Ltd.
Common Stock 622K $7.75M $12.46 Aug 2, 2022 By F2-TPO Investments, LLC
Common Stock 537K $6.7M $12.46 Aug 2, 2022 By F2 Bioscience I 2017 Ltd.
Common Stock 325K $4.05M $12.46 Aug 2, 2022 By F2 MG Ltd.
Common Stock 215K $2.68M $12.46 Aug 2, 2022 By F2 MC, LLC
Common Stock 208K $2.59M $12.46 Aug 2, 2022 By Morana Jovan-Embiricos
Common Stock 105K $1.31M $12.46 Aug 2, 2022 By F2 GC, LLC
Common Stock 71.6K $892K $12.46 Aug 2, 2022 By F2 Bio TD, LLC

Transactions reported by F2 Vision SCS for Cullinan Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.